Pilot production payment for LabTech
Friday, 12 September, 2008
LabTech Systems (ASX: LBT) has sent pilot production units of its MicroStreak technology to partner bioMérieux, triggering a $1.74 million milestone payment.
LabTech Systems signed an exclusive license agreement with bioMérieux last year. The French diagnostics giant will market the technology under its PREVI Isola brand.
The technology is a high-speed robotic platform for agar plate streaking in microbiology and pathology labs.
This payment brings the total revenue from the agreement to $6.67 million.
The PREVI Isola will be on sale later this year. LabTech Systems also expects royalty payments to begin from January 1 next year.
'Smart bandage' heals and monitors simultaneously
By embedding tiny, multi-functional nanomaterials into hydrogel dressing, this smart bandage...
This AI model judges molecular stability on its own, researchers say
Korean researchers have developed an artificial intelligence model that, they say, understands...
In the face of change: how Antarctic microbes can survive a 95°C temperature span
Analysis of microbial soil samples has helped Australian scientists understand the resilience of...
